Sutro Biopharma, Inc(NASDAQ:STRO) 
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's prod...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.57
H 0.59
L 0.54
C 0.54
V 1,133,180
10EMA 0.54
20EMA 0.54
60EMA 0.54
120EMA 0.54
250EMA 0.54